Journal of Hematology & Oncology

official impact factor 2.93

Open Access Short report

Temozolomide and cisplatin in relapsed/refractory acute leukemia

Karen Seiter*, Sreedhar Katragadda, Doris Ponce, Muhammad Rasul and Nasir Ahmed

Journal of Hematology & Oncology 2009, 2:21 doi:10.1186/1756-8722-2-21

No comments have yet been made on this article.

Post a comment